Study provides insights into the molecular changes that drive hypertrophic cardiomyopathy (HCM), a thickening and stiffening of heart muscle that can lead to heart failure or sudden cardiac arrest.

Learn how to distinguish between medication side effects and obstructive hypertrophic cardiomyopathy progression.

Learn how to recognize subtle signs of obstructive hypertrophic cardiomyopathy progression, track symptoms, and communicate ...

Explore surgical myectomy and alcohol septal ablation for obstructive hypertrophic cardiomyopathy, including candidacy, ...

An experimental drug has been shown to improve symptoms, exercise capacity and heart failure status in patients with an ...

Experiments on engineered micro-heart tissue showed cross talk between fibroblasts and cardiomyocytes in diseased tissue.

Over the last 25 years, there have been low rates of device failures and death in patients who received an ICD.

It's often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in one in 500 people. Dr. Said Alsidawi, a Mayo Clinic cardiologist, says the problem is ...

What is Hypertrophic Cardiomyopathy (HCM)? Hypertrophic cardiomyopathy (HCM) is a condition that affects the muscle layer of the heart in patients without any underlying heart problems or systemic ...

Hypertrophic cardiomyopathy is a genetic heart condition where the heart muscles become thickened and stiff, making it difficult for the heart to pump blood around the body effectively. Usually the ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Bighearted 5K 2026, to benefit the HCMA, seeks virtual & in-person runners & walkers to keep families whole, one step ...